| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |